Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG).

Demir O, Cetin B, Alkan A, Sengul N, Sencan C, Onur ID, Ugraklı M, Akbas S, Ercin E, Sahin E, Celebi A, Sucuoglu Isleyen Z, Sakalar T, Sim S, Ballı S, Karan C, Topal A, Sakin A, Agyol Y, Akdag G, Ozdemir M, Tomak L, Kılıckap S

Open source

DOI: 10.1097/cji.0000000000000604
Published: 2026 Sep 1
Container: Journal of immunotherapy (Hagerstown, Md. : 1997)
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/cji.0000000000000604,
  title = {Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG).},
  author = {Demir O and Cetin B and Alkan A and Sengul N and Sencan C and Onur ID and Ugraklı M and Akbas S and Ercin E and Sahin E and Celebi A and Sucuoglu Isleyen Z and Sakalar T and Sim S and Ballı S and Karan C and Topal A and Sakin A and Agyol Y and Akdag G and Ozdemir M and Tomak L and Kılıckap S},
  year = {2026},
  journal = {Journal of immunotherapy (Hagerstown, Md. : 1997)},
  doi = {10.1097/cji.0000000000000604},
  url = {https://doi.org/10.1097/cji.0000000000000604}
}

RIS

TY  - JOUR
TI  - Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG).
AU  - Demir O
AU  - Cetin B
AU  - Alkan A
AU  - Sengul N
AU  - Sencan C
AU  - Onur ID
AU  - Ugraklı M
AU  - Akbas S
AU  - Ercin E
AU  - Sahin E
AU  - Celebi A
AU  - Sucuoglu Isleyen Z
AU  - Sakalar T
AU  - Sim S
AU  - Ballı S
AU  - Karan C
AU  - Topal A
AU  - Sakin A
AU  - Agyol Y
AU  - Akdag G
AU  - Ozdemir M
AU  - Tomak L
AU  - Kılıckap S
PY  - 2026
JO  - Journal of immunotherapy (Hagerstown, Md. : 1997)
DO  - 10.1097/cji.0000000000000604
UR  - https://doi.org/10.1097/cji.0000000000000604
ER  -

APA

O, D., B, C., A, A., N, S., C, S., ID, O., M, U., S, A., E, E., E, S., A, C., Z, S. I., T, S., S, S., S, B., C, K., A, T., A, S., Y, A., G, A., M, O., L, T., & S, K. (2026). Side Effect Management of Immune-related Hepatotoxicity Due to Immune Checkpoint Inhibitors: A Multicenter Study by the Turkish Oncology Group (TOG).. Journal of immunotherapy (Hagerstown, Md. : 1997). https://doi.org/10.1097/cji.0000000000000604

Source records

pubmed · retrieved 2026-09-27T15:57:32.344Z
europe-pmc · retrieved 2026-09-27T15:57:32.362Z